Thomson Medical Group priced $225m 3-year senior bond in maiden bond offering

Proceeds will be used to refinance its existing debts and extend its debt maturity profile.

Thomson Medical Group Limited has priced a $225m SGD senior bond due 2022 in its maiden bond offering with an interest of 4.8% per annum, an announcement revealed.

The firm said that the bond offering received is 2.0x oversubscribed and is expected to be issued on 18 July. It intends to utilise the proceeds to refinance its existing debts and extend its debt maturity profile.

This comes after the announcement of Thomson Medical’s $500m multicurrency debt issuance programme, which aims to finance its borrowings, expansions and capital expenditure.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia